These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 32216034)

  • 1. Diabetic eye screening with variable screening intervals based on individual risk factors is safe and effective in ophthalmic practice.
    Estil S; Steinarsson AÞ; Einarsson S; Aspelund T; Stefánsson E
    Acta Ophthalmol; 2020 Jun; 98(4):343-346. PubMed ID: 32216034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patients' Adherence to Recommended Follow-up Eye Care After Diabetic Retinopathy Screening in a Publicly Funded County Clinic and Factors Associated With Follow-up Eye Care Use.
    Keenum Z; McGwin G; Witherspoon CD; Haller JA; Clark ME; Owsley C
    JAMA Ophthalmol; 2016 Nov; 134(11):1221-1228. PubMed ID: 27632231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Individual risk assessment and information technology to optimise screening frequency for diabetic retinopathy.
    Aspelund T; Thornórisdóttir O; Olafsdottir E; Gudmundsdottir A; Einarsdóttir AB; Mehlsen J; Einarsson S; Pálsson O; Einarsson G; Bek T; Stefánsson E
    Diabetologia; 2011 Oct; 54(10):2525-32. PubMed ID: 21792613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetic retinopathy. Screening and prevention of blindness. A doctoral thesis.
    Kristinsson JK
    Acta Ophthalmol Scand Suppl; 1997; (223):1-76. PubMed ID: 9559048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Automated Teleretinal Screening Program for Diabetic Retinopathy.
    Walton OB; Garoon RB; Weng CY; Gross J; Young AK; Camero KA; Jin H; Carvounis PE; Coffee RE; Chu YI
    JAMA Ophthalmol; 2016 Feb; 134(2):204-9. PubMed ID: 26720694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First Incidence and Progression Study for Diabetic Retinopathy in Portugal, the RETINODIAB Study: Evaluation of the Screening Program for Lisbon Region.
    Dutra Medeiros M; Mesquita E; Gardete-Correia L; Moita J; Genro V; Papoila AL; Amaral-Turkman A; Raposo JF
    Ophthalmology; 2015 Dec; 122(12):2473-81. PubMed ID: 26383994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of sight-threatening diabetic retinopathy in people with Type 2 diabetes mellitus and numbers needed to screen: a systematic review.
    Groeneveld Y; Tavenier D; Blom JW; Polak BCP
    Diabet Med; 2019 Oct; 36(10):1199-1208. PubMed ID: 30677170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of sight-threatening diabetic retinopathy in an established urban screening programme: An 11-year cohort study.
    Cheyne CP; Burgess PI; Broadbent DM; García-Fiñana M; Stratton IM; Criddle T; Wang A; Alshukri A; Rahni MM; Vazquez-Arango P; Vora JP; Harding SP;
    Diabet Med; 2021 Sep; 38(9):e14583. PubMed ID: 33830513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and cost-effectiveness of individualised screening for diabetic retinopathy: the ISDR open-label, equivalence RCT.
    Broadbent DM; Wang A; Cheyne CP; James M; Lathe J; Stratton IM; Roberts J; Moitt T; Vora JP; Gabbay M; García-Fiñana M; Harding SP;
    Diabetologia; 2021 Jan; 64(1):56-69. PubMed ID: 33146763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vibration perception threshold for sight-threatening retinopathy screening in type 2 diabetic outpatients.
    Shen J; Hu Y; Liu F; Zeng H; Li L; Zhao J; Zhao J; Zheng T; Lu H; Lu F; Bao Y; Jia W
    Diabetes Metab Res Rev; 2013 Oct; 29(7):525-31. PubMed ID: 23658123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Individualised risk assessment for diabetic retinopathy and optimisation of screening intervals: a scientific approach to reducing healthcare costs.
    Lund SH; Aspelund T; Kirby P; Russell G; Einarsson S; Palsson O; Stefánsson E
    Br J Ophthalmol; 2016 May; 100(5):683-7. PubMed ID: 26377413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biennial eye screening in patients with diabetes without retinopathy: 10-year experience.
    Olafsdóttir E; Stefánsson E
    Br J Ophthalmol; 2007 Dec; 91(12):1599-601. PubMed ID: 17627978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of sight-threatening retinopathy in patients with type 2 diabetes in the Liverpool Diabetic Eye Study: a cohort study.
    Younis N; Broadbent DM; Vora JP; Harding SP;
    Lancet; 2003 Jan; 361(9353):195-200. PubMed ID: 12547541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of Autonomous Point-of-Care Diabetic Retinopathy Screening for Pediatric Patients With Diabetes.
    Wolf RM; Channa R; Abramoff MD; Lehmann HP
    JAMA Ophthalmol; 2020 Oct; 138(10):1063-1069. PubMed ID: 32880616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening intervals for diabetic retinopathy and incidence of visual loss: a systematic review.
    Echouffo-Tcheugui JB; Ali MK; Roglic G; Hayward RA; Narayan KM
    Diabet Med; 2013 Nov; 30(11):1272-92. PubMed ID: 23819487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progression of diabetes retinal status within community screening programs and potential implications for screening intervals.
    Leese GP; Stratton IM; Land M; Bachmann MO; Jones C; Scanlon P; Looker HC; Ferguson B;
    Diabetes Care; 2015 Mar; 38(3):488-94. PubMed ID: 25524948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of a model for the prediction of retinopathy in persons with type 1 diabetes.
    Schreur V; Ng H; Nijpels G; Stefánsson E; Tack CJ; Klevering BJ; de Jong EK; Hoyng CB; Keunen JEE; van der Heijden AA
    Br J Ophthalmol; 2021 Sep; 105(9):1286-1288. PubMed ID: 30824420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of diabetic retinopathy in patients with recently diagnosed diabetes mellitus.
    Lee KM; Sum WM
    Clin Exp Optom; 2011 Jul; 94(4):371-5. PubMed ID: 21323731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Individualised screening for diabetic retinopathy: the ISDR study-rationale, design and methodology for a randomised controlled trial comparing annual and individualised risk-based variable-interval screening.
    Broadbent DM; Sampson CJ; Wang A; Howard L; Williams AE; Howlin SU; Appelbe D; Moitt T; Cheyne CP; Rahni MM; Kelly J; Collins J; García-Fiñana M; Stratton IM; James M; Harding SP;
    BMJ Open; 2019 Jun; 9(6):e025788. PubMed ID: 31213445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. External validation of a risk assessment model to adjust the frequency of eye-screening visits in patients with diabetes mellitus.
    Soto-Pedre E; Pinies JA; Hernaez-Ortega MC
    J Diabetes Complications; 2015; 29(4):508-11. PubMed ID: 25725582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.